345 related articles for article (PubMed ID: 30045293)
1. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
2. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
3. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
4. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
5. Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus.
Ahn JH; Jung SI; Yim SU; Kim SW; Hwang EC; Kwon DD
J Korean Med Sci; 2016 Sep; 31(9):1464-71. PubMed ID: 27510392
[TBL] [Abstract][Full Text] [Related]
6. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
Zeng S; Gan HX; Xu JX; Liu JY
Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870
[TBL] [Abstract][Full Text] [Related]
7. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract][Full Text] [Related]
8. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
Yao X; Liu H; Xu H
Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791
[TBL] [Abstract][Full Text] [Related]
10. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
12. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
13. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
[TBL] [Abstract][Full Text] [Related]
14. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
15. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis.
Xin WX; Fang L; Fang QL; Zheng XW; Ding HY; Huang P
Medicine (Baltimore); 2018 Mar; 97(9):e0035. PubMed ID: 29489653
[TBL] [Abstract][Full Text] [Related]
16. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
17. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
18. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
Zhou JB; Tang X; Han M; Yang J; Simó R
Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679
[TBL] [Abstract][Full Text] [Related]
19. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
[TBL] [Abstract][Full Text] [Related]
20. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
Wang SB; Lei KJ; Liu JP; Jia YM
Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]